Aytu BioScience
Carl Dockery is the current Director at Aytu BioScience. Carl has previous experience working as a financial advisor at Allen & Company of Florida from January 2001 to December 2006. Carl's responsibilities included advising corporate clients on portfolio construction policies, oversight of investment managers, and day to day management of closely held asset pools. Carl also has experience working as a board of directors and corporate officer at Crossroads Insurance Company from January 1988 to December 2008. As chief risk analyst, their responsibilities included oversight of investment managers for institutional assets, structuring both firms’ risk tiers, placing reinsurance, and minimizing claim volatility through the implementation of proactive settlement strategies.
Carl Dockery pursued their undergraduate degree at Southeastern University in the field of Humanities. Carl then went on to study at Denver Seminary for their graduate degree in the field of Philosophy of Religion.
This person is not in the org chart
This person is not in any offices
Aytu BioScience
2 followers
Aytu BioPharma (NASDAQ: AYTU) is a specialty pharmaceutical company with a growing commercial portfolio of prescription therapeutics and consumer health products, including ADHD and pediatrics medications. Their evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As they continue on this trajectory, they are building a complimentary therapeutic development pipeline that will address significant unmet needs.